Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Perit Dial Int ; 41(3): 337-340, 2021 05.
Article in English | MEDLINE | ID: mdl-33025862

ABSTRACT

Infections with Listeria monocytogenes (LM) are very uncommon and severe especially in immunocompromised people. We report a continuous cycling peritoneal dialysis (CCPD) patient who presented initially disseminated listeriosis with peritonitis. He was successfully treated with intraperitoneal and intravenous ampicillin but died unfortunately from a cardiorespiratory arrest due to food inhalation. It is the 20th case of such peritonitis mentioned among PD patients and the first reported in Belgium. This case illustrates the importance of a systematic approach to get quick diagnosis and effective antibiotic readjustment. Empiric therapy is not effective on Listeria which is naturally resistant to cephalosporins and poorly sensitive to vancomycin. Ampicillin is the first-line antibiotic. In case of penicillin allergy, trimethoprim-sulfamethoxazole or erythromycin can be used successfully. Identification of LM serotype has a prognostic value. PD educative programmes should recommend to avoid unpasteurized dairy products to prevent listeriosis.


Subject(s)
Listeria , Listeriosis , Peritoneal Dialysis , Peritonitis , Ampicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Humans , Listeriosis/diagnosis , Listeriosis/drug therapy , Male , Peritoneal Dialysis/adverse effects , Peritonitis/diagnosis , Peritonitis/drug therapy , Peritonitis/etiology
2.
Acta Chir Belg ; 119(6): 400-403, 2019 Dec.
Article in English | MEDLINE | ID: mdl-29879867

ABSTRACT

Introduction: Small bowel intussusception is a rare complication after Roux-en-Y gastric bypass (RYGB) whose incidence tends to increase. This rising could be explained by an increasing bariatric surgery over the last two decades and by a better recognition of this potential complication. Patient and methods: We report a case of jejunojejunal intussusception in 33-year-old woman 2 years following a laparoscopic RYGB. She was taken to the operating room for exploratory laparotomy. Results: Its diagnosis is based on a combination of physical, radiological, and operative findings. The surgical exploration confirmed an anterograde jejunojejunal intussusception through the Roux-en-Y anastomosis. A lead point was not identified. We performed the resection of the blind extremity of the biliopancreatic limb to prevent recurrence. Conclusions: Small bowel intussusception is a rare long-term complication after RYGB. The underlying causative mechanism remains unclear. This rare condition may cause obstruction and lead to bowel necrosis if not recognized and treated promptly.


Subject(s)
Anastomosis, Roux-en-Y/adverse effects , Gastric Bypass/adverse effects , Intussusception/surgery , Jejunal Diseases/surgery , Obesity, Morbid/surgery , Adult , Female , Humans , Intussusception/etiology , Jejunal Diseases/etiology , Laparoscopy
3.
Acta Chir Belg ; 117(5): 295-302, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28438090

ABSTRACT

BACKGROUND: Abdominal wall hernias are a common problem. Composite meshes placed intraperitoneally for abdominal wall hernia repair are widely used. This registry evaluated the safety and efficacy of one specific composite mesh with polypropylene and expanded polytetrafluoroethylene (Intramesh® T1) in laparoscopic ventral hernia repair. METHODS: A prospective multicentre registry with data from seven centres was collected between January 2013 and September 2014. Primary endpoint was recurrence rate at 12 months determined by clinical examination. Secondary outcome measures included intraoperative complications, complications during hospitalisation and at 1-month and 12-months follow-up. RESULTS: The registry included 90 patients (30 female and 60 male). Fifty-five patients (61.1%) presented with primary ventral hernias and 35 patients (38.9%) with incisional ventral hernias. Median hernia size was 4 cm2. Intraoperative complications were reported in two patients (2.2%). Complications during hospitalisation were reported in four (4.4%) patients. At 1-month follow-up, 17 (18.9%) patients had postoperative complications, of which 5 complications were major and 19 were minor. Late complications at 12-months were observed in 10 patients (11.1%), of which 2 were major and 8 minor complications. CONCLUSION: Intramesh® T1 is a safe and effective composite mesh with favourable short and midterm outcome and morbidity. (NCT01816867).


Subject(s)
Hernia, Ventral/surgery , Laparoscopy/instrumentation , Surgical Mesh , Female , Fluorocarbon Polymers , Follow-Up Studies , Humans , Intraoperative Complications , Male , Polypropylenes , Postoperative Complications , Prospective Studies , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...